+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Placenta Growth Factor"

Placenta growth factor inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Placenta growth factor inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-VEGF Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Anti-VEGF Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 422 Pages
  • Global
Placenta Growth Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Placenta Growth Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 84 Pages
  • Global
From
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 120 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Placenta Growth Factor (PGF) market is a subset of the cardiovascular drugs market. PGF is a naturally occurring protein that is found in the placenta of pregnant women. It has been studied for its potential to treat cardiovascular diseases such as coronary artery disease, heart failure, and stroke. PGF has been shown to have anti-inflammatory and anti-apoptotic properties, which may help to reduce the risk of cardiovascular events. Additionally, PGF has been studied for its potential to improve the function of the endothelium, the inner lining of the blood vessels. PGF is currently being studied in clinical trials for its potential to treat cardiovascular diseases. Several companies are developing PGF-based therapies, including Amgen, Novartis, and Pfizer. Additionally, several biotechnology companies are researching PGF-based therapies, such as Athersys, Inc., and Pluristem Therapeutics, Inc. Show Less Read more